The role of trimethoprim/sulfamethoxazole in the treatment of Wegener's granulomatosis.
Leavitt
R Y
RY
NIAID, NIH, Bethesda, MD 20892
Hoffman
G S
GS
Fauci
A S
AS
D000890:Anti-Infective Agents / Q000627:therapeutic use; D004338:Drug Combinations / Q000627:therapeutic use; D014890:Granulomatosis with Polyangiitis / Q000188:drug therapy*; D006801:Humans; D012107:Research Design; D013420:Sulfamethoxazole / Q000627:therapeutic use*; D014295:Trimethoprim / Q000627:therapeutic use*; D015662:Trimethoprim, Sulfamethoxazole Drug Combination
D000890:Anti-Infective Agents; D004338:Drug Combinations; D015662:Trimethoprim, Sulfamethoxazole Drug Combination; D014295:Trimethoprim; D013420:Sulfamethoxazole